These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Human Induced Pluripotent Stem Cells in the Curative Treatment of Diabetes and Potential Impediments Ahead. Dadheech N; James Shapiro AM Adv Exp Med Biol; 2019; 1144():25-35. PubMed ID: 30569414 [TBL] [Abstract][Full Text] [Related]
4. Differentiation of human pluripotent stem cells into β-cells: Potential and challenges. Quiskamp N; Bruin JE; Kieffer TJ Best Pract Res Clin Endocrinol Metab; 2015 Dec; 29(6):833-47. PubMed ID: 26696513 [TBL] [Abstract][Full Text] [Related]
5. Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes. Hogrebe NJ; Ishahak M; Millman JR Cell Stem Cell; 2023 May; 30(5):530-548. PubMed ID: 37146579 [TBL] [Abstract][Full Text] [Related]
6. Recent Advances in the Generation of β-Cells from Induced Pluripotent Stem Cells as a Potential Cure for Diabetes Mellitus. Agrawal A; Narayan G; Gogoi R; Thummer RP Adv Exp Med Biol; 2021; 1347():1-27. PubMed ID: 34426962 [TBL] [Abstract][Full Text] [Related]
7. Generation of insulin-producing cells from pluripotent stem cells: from the selection of cell sources to the optimization of protocols. Liew CG Rev Diabet Stud; 2010; 7(2):82-92. PubMed ID: 21060967 [TBL] [Abstract][Full Text] [Related]
8. Differentiation and transplantation of functional pancreatic beta cells generated from induced pluripotent stem cells derived from a type 1 diabetes mouse model. Jeon K; Lim H; Kim JH; Thuan NV; Park SH; Lim YM; Choi HY; Lee ER; Kim JH; Lee MS; Cho SG Stem Cells Dev; 2012 Sep; 21(14):2642-55. PubMed ID: 22512788 [TBL] [Abstract][Full Text] [Related]
9. Generation and application of novel hES cell reporter lines for the differentiation and maturation of hPS cell-derived islet-like clusters. Zanfrini E; Bandral M; Jarc L; Ramirez-Torres MA; Pezzolla D; Kufrin V; Rodriguez-Aznar E; Avila AKM; Cohrs C; Speier S; Neumann K; Gavalas A Sci Rep; 2024 Aug; 14(1):19863. PubMed ID: 39191834 [TBL] [Abstract][Full Text] [Related]
10. Comparison of Cardiomyocyte Differentiation Potential Between Type 1 Diabetic Donor- and Nondiabetic Donor-Derived Induced Pluripotent Stem Cells. Kikuchi C; Bienengraeber M; Canfield S; Koopmeiner A; Schäfer R; Bosnjak ZJ; Bai X Cell Transplant; 2015; 24(12):2491-504. PubMed ID: 25562386 [TBL] [Abstract][Full Text] [Related]
11. Generation of pancreatic insulin-producing cells from rhesus monkey induced pluripotent stem cells. Zhu FF; Zhang PB; Zhang DH; Sui X; Yin M; Xiang TT; Shi Y; Ding MX; Deng H Diabetologia; 2011 Sep; 54(9):2325-36. PubMed ID: 21755313 [TBL] [Abstract][Full Text] [Related]
12. Generation of pancreatic β cells for treatment of diabetes: advances and challenges. Shahjalal HM; Abdal Dayem A; Lim KM; Jeon TI; Cho SG Stem Cell Res Ther; 2018 Dec; 9(1):355. PubMed ID: 30594258 [TBL] [Abstract][Full Text] [Related]
13. Genome-wide analysis of PDX1 target genes in human pancreatic progenitors. Wang X; Sterr M; Burtscher I; Chen S; Hieronimus A; Machicao F; Staiger H; Häring HU; Lederer G; Meitinger T; Cernilogar FM; Schotta G; Irmler M; Beckers J; Hrabě de Angelis M; Ray M; Wright CVE; Bakhti M; Lickert H Mol Metab; 2018 Mar; 9():57-68. PubMed ID: 29396371 [TBL] [Abstract][Full Text] [Related]
14. Advances in the Generation of Functional β-cells from Induced Pluripotent Stem Cells As a Cure for Diabetes Mellitus. Kalra K; Chandrabose ST; Ramasamy TS; Kasim NHBA Curr Drug Targets; 2018; 19(13):1463-1477. PubMed ID: 29874998 [TBL] [Abstract][Full Text] [Related]
15. Recent Advances in Disease Modeling and Drug Discovery for Diabetes Mellitus Using Induced Pluripotent Stem Cells. Kawser Hossain M; Abdal Dayem A; Han J; Kumar Saha S; Yang GM; Choi HY; Cho SG Int J Mol Sci; 2016 Feb; 17(2):256. PubMed ID: 26907255 [TBL] [Abstract][Full Text] [Related]
16. Reproducible preparation of spheroids of pancreatic hormone positive cells from human iPS cells: An in vitro study. Konagaya S; Iwata H Biochim Biophys Acta; 2016 Sep; 1860(9):2008-16. PubMed ID: 27180174 [TBL] [Abstract][Full Text] [Related]
17. Induced pluripotent stem cell macrophages present antigen to proinsulin-specific T cell receptors from donor-matched islet-infiltrating T cells in type 1 diabetes. Joshi K; Elso C; Motazedian A; Labonne T; Schiesser JV; Cameron F; Mannering SI; Elefanty AG; Stanley EG Diabetologia; 2019 Dec; 62(12):2245-2251. PubMed ID: 31511930 [TBL] [Abstract][Full Text] [Related]
18. Oxygenated Scaffolds for Pancreatic Endocrine Differentiation from Induced Pluripotent Stem Cells. Huang H; Karanth SS; Guan Y; Freeman S; Soron R; Godovich DS; Guan J; Ye K; Jin S Adv Healthc Mater; 2024 Jan; 13(3):e2302275. PubMed ID: 37885129 [TBL] [Abstract][Full Text] [Related]
19. Generation of Pancreatic β-cells From iPSCs and their Potential for Type 1 Diabetes Mellitus Replacement Therapy and Modelling. Csobonyeiova M; Polak S; Danisovic L Exp Clin Endocrinol Diabetes; 2020 May; 128(5):339-346. PubMed ID: 30114722 [TBL] [Abstract][Full Text] [Related]
20. Demethylation of induced pluripotent stem cells from type 1 diabetic patients enhances differentiation into functional pancreatic β cells. Manzar GS; Kim EM; Zavazava N J Biol Chem; 2017 Aug; 292(34):14066-14079. PubMed ID: 28360105 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]